Macro monthly | Slower progress | Article – HSBC VisionGo
- Rising case numbers and lockdowns in parts of the world are denting optimism but vaccine rollouts are cause for hope
- Inflationary pressures remain acute, but some signs of a peak in input prices
- We raised our 2021 eurozone GDP growth forecast to 4.9% (from 4.4%) but trimmed UK GDP to 6.7% (from 7.1%)
Despite some of the discourse in financial markets in recent times, things are getting slightly better on the pandemic front in some parts of the world.
Different pictures across the world
COVID-19 case numbers remain high in Asia...
Case numbers are still high in much of Asia, lockdowns have been re-introduced and extended in some Australian states and the Delta variant is leading to higher case numbers in various parts of the world. But there is some better news in other places.
…but are broadly stable across Europe
Across Europe, the number of cases are still broadly stable, although rising more rapidly in Germany and the UK (Chart 1), and intensive care unit occupancy rates for COVID-19 patients remain relatively contained. Most European countries are getting closer to the vaccination target of 70% of the population, which they had set out to meet by the end of summer.
There is growing evidence of vaccine effectiveness
And there is also growing evidence of vaccine effectiveness across the world. Even with cases at more than 30k per day, UK hospitalisations stayed much lower than in previous waves, and the country has now not seen any excess deaths since mid-February, when all over-50s could have received their first vaccine.
Elsewhere, in highly-vaccinated parts of the world, we’re seeing hospitalisation rates and deaths rise much more slowly than cases. Whilst there is a long way to go with the global vaccine rollout, this is clearly good news.
Cost-push inflation may have peaked
Inflation still elevated but may be receding
There may be emerging signs that the worst of the cost-push inflationary pressures is behind us too, especially in Asia. Shipping costs are elevated and firms continue to face higher input costs, but global shipping volumes have edged down, consumer spending keeps rotating away from goods, and some commodity prices, such as lumber, oil and precious metals, are falling. The Manheim used vehicle price index in the US has now fallen 3% in two months.
Consumer spending revival likely to be Q3 and beyond
Q2 GDP data have started to roll in, too, with a mixed bag of results. We think the revival in consumer spending in much of the world is more likely to be seen in Q3 and beyond, with restrictions being lifted across Europe at the start of the quarter, and in Asia this is likely to come much later. However, in terms of sequential momentum, global industrial and trade activity may have peaked in May based on PMIs and other business surveys across the world. The global economy, in aggregate, is still improving, but at a slower pace.
Our GDP growth forecasts
We have raised our 2021 eurozone GDP forecast...
We raised our 2021 eurozone GDP growth forecast to 4.9% (from 4.4%) mostly due to stronger-than-expected Q2 GDP growth of 2.0% q-o-q. Leading indicators for Q3 suggest that a rapid pace of expansion has continued, even if it has come off its recent highs as the growth impulse from unlocking wanes. This means that we lock in most of the upside news for Q2 without assuming much near-term payback in terms of a weaker Q3 or beyond.
…but have lowered it for the UK
Meanwhile, in the UK, we have lowered our 2021 GDP growth forecast to 6.7% (from 7.1%) given the lower-than-expected Q2 print. We might normally expect ‘payback’ in the summer but we are not revising up our Q3 forecasts as the rain, ‘pingdemic’ and other supply shortages appear to have put the breaks on growth. Instead, we are slightly revising up growth in Q4 and Q1 2022, and raise our 2022 GDP growth forecast to 5.2% (from 5.1%).
This document is for information purposes only and should not be regarded as an offer to sell or as a solicitation of an offer to buy the securities or other investment products mentioned in it and/or to participate in any trading strategy. Information in this document is general and should not be construed as investment advice, given it has been prepared without taking account of the objectives, financial situation or needs of any particular investor. Accordingly, investors should, before acting on it, consider the appropriateness of the information, having regard to their objectives, financial situation and needs and, if necessary, seek professional investment and tax advice.
Certain investment products mentioned in this document may not be eligible for sale in some states or countries, and they may not be suitable for all types of investors. Investors should consult with their HSBC representative regarding the suitability of the investment products mentioned in this document and take into account their specific investment objectives, financial situation or particular needs before making a commitment to purchase investment products.
The value of and the income produced by the investment products mentioned in this document may fluctuate, so that an investor may get back less than originally invested. Certain high-volatility investments can be subject to sudden and large falls in value that could equal or exceed the amount invested. Value and income from investment products may be adversely affected by exchange rates, interest rates, or other factors. Past performance of a particular investment product is not indicative of future results.
HSBC and its affiliates will from time to time sell to and buy from customers the securities/instruments (including derivatives) of companies covered here on a principal or agency basis.
Whether, or in what time frame, an update of this information will be published is not determined in advance.
This report is dated as at 27 August 2021.
All market data included in this report are dated as at close 26 August 2021, unless a different date and/or a specific time of day is indicated in the report.
HSBC has procedures in place to identify and manage any potential conflicts of interest that arise in connection with its Research business. HSBC's analysts and its other staff who are involved in the preparation and dissemination of Research operate and have a management reporting line independent of HSBC's Investment Banking business. Information Barrier procedures are in place between the Investment Banking, Principal Trading, and Research businesses to ensure that any confidential and/or price sensitive information is handled in an appropriate manner.
You are not permitted to use, for reference, any data in this document for the purpose of (i) determining the interest payable, or other sums due, under loan agreements or under other financial contracts or instruments, (ii) determining the price at which a financial instrument may be bought or sold or traded or redeemed, or the value of a financial instrument, and/or (iii) measuring the performance of a financial instrument or of an investment fund.